Singapore, April 23 -- Jamjoom Pharma, one of the fastest-growing pharmaceutical companies in Saudi Arabia and across MEA, has announced the signing of a Memorandum of Understanding (MoU) with Caritas Egypt, aimed at launching a comprehensive national initiative for early detection of ocular surface disorders and raising health awareness among the most vulnerable groups.

This partnership comes in line with Egypt Vision 2030 and the presidential public health initiatives, as Jamjoom Pharma seeks through it to leverage its technical and medical expertise to serve Egyptian society.

Under this agreement, signed by Dr Ali Yehia, General Manager and Cluster Head of Jamjoom Pharma in Egypt and North Africa, and Dr Ayman Sadek, Genera...